Peritoneal tuberculosis after imatinib therapy

Arch Intern Med. 2009 Feb 9;169(3):312-3. doi: 10.1001/archinternmed.2008.581.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects*
  • Antitubercular Agents / therapeutic use
  • Benzamides
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy
  • Lymphopenia / chemically induced
  • Male
  • Opportunistic Infections / chemically induced
  • Opportunistic Infections / complications*
  • Opportunistic Infections / drug therapy
  • Peritonitis / microbiology
  • Peritonitis, Tuberculous / chemically induced
  • Peritonitis, Tuberculous / complications*
  • Peritonitis, Tuberculous / drug therapy
  • Piperazines / administration & dosage
  • Piperazines / adverse effects*
  • Pyrimidines / administration & dosage
  • Pyrimidines / adverse effects*

Substances

  • Antineoplastic Agents
  • Antitubercular Agents
  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate